Altimmune (NASDAQ:ALT) executives used the company’s year-end 2025 results call to outline preparations for a pivotal Phase 3 ...
Conference Call Participants. Lee Roth - Burns McClellan, Inc. Jiale Song - Jefferies LLC, Research Division Jasmine Fels - Barclays Bank PLC, Research Division Dominic Lorenzi - ...
Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, today announced GLP-1 Flex Care, a new offering that will support employers looking to increase access to GLP-1 ...
CEO Christopher Missling presented an update on the company’s central nervous system pipeline at the firm’s 46th Annual Healthcare Conference, highlighting late-stage data for its oral Alzheimer’s ...
The presentations include late-breaking clinical data, oral sessions and posters highlighting real-world outcomes, cardiac energetics, hospitalization impact, left ventricular ejection fraction (LVEF) ...
Investor focus is shifting to upcoming clinical catalysts for MetaVia following a period of significant foundational progress. The company has secured crucial intellectual property and generated new ...
Aaron Arman, Superintendent Pharmacist at CheqUp, has shared the things you should consider when starting weight loss jabs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results